Report Detail

Pharma & Healthcare COVID-19 Impact on Global Veterinary Clostridium Vaccines, Market Insights and Forecast to 2026

  • RnM4084203
  • |
  • 30 June, 2020
  • |
  • Global
  • |
  • 149 Pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

1 Study Coverage

  • 1.1 Veterinary Clostridium Vaccines Product Introduction
  • 1.2 Market Segments
  • 1.3 Key Veterinary Clostridium Vaccines Manufacturers Covered: Ranking by Revenue
  • 1.4 Market by Type
    • 1.4.1 Global Veterinary Clostridium Vaccines Market Size Growth Rate by Type
    • 1.4.2 Bacterins
    • 1.4.3 Toxoids
    • 1.4.4 Mixtures of Bacterins and Toxoids
  • 1.5 Market by Application
    • 1.5.1 Global Veterinary Clostridium Vaccines Market Size Growth Rate by Application
    • 1.5.2 Swine
    • 1.5.3 Bovine
    • 1.5.4 Poultry
    • 1.5.5 Others
  • 1.6 Coronavirus Disease 2019 (Covid-19): Veterinary Clostridium Vaccines Industry Impact
    • 1.6.1 How the Covid-19 is Affecting the Veterinary Clostridium Vaccines Industry
      • 1.6.1.1 Veterinary Clostridium Vaccines Business Impact Assessment - Covid-19
      • 1.6.1.2 Supply Chain Challenges
      • 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
    • 1.6.2 Market Trends and Veterinary Clostridium Vaccines Potential Opportunities in the COVID-19 Landscape
    • 1.6.3 Measures / Proposal against Covid-19
      • 1.6.3.1 Government Measures to Combat Covid-19 Impact
      • 1.6.3.2 Proposal for Veterinary Clostridium Vaccines Players to Combat Covid-19 Impact
  • 1.7 Study Objectives
  • 1.8 Years Considered

2 Executive Summary

  • 2.1 Global Veterinary Clostridium Vaccines Market Size Estimates and Forecasts
    • 2.1.1 Global Veterinary Clostridium Vaccines Revenue 2015-2026
    • 2.1.2 Global Veterinary Clostridium Vaccines Sales 2015-2026
  • 2.2 Veterinary Clostridium Vaccines Market Size by Region: 2020 Versus 2026
    • 2.2.1 Global Veterinary Clostridium Vaccines Retrospective Market Scenario in Sales by Region: 2015-2020
    • 2.2.2 Global Veterinary Clostridium Vaccines Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Veterinary Clostridium Vaccines Competitor Landscape by Players

  • 3.1 Veterinary Clostridium Vaccines Sales by Manufacturers
    • 3.1.1 Veterinary Clostridium Vaccines Sales by Manufacturers (2015-2020)
    • 3.1.2 Veterinary Clostridium Vaccines Sales Market Share by Manufacturers (2015-2020)
  • 3.2 Veterinary Clostridium Vaccines Revenue by Manufacturers
    • 3.2.1 Veterinary Clostridium Vaccines Revenue by Manufacturers (2015-2020)
    • 3.2.2 Veterinary Clostridium Vaccines Revenue Share by Manufacturers (2015-2020)
    • 3.2.3 Global Veterinary Clostridium Vaccines Market Concentration Ratio (CR5 and HHI) (2015-2020)
    • 3.2.4 Global Top 10 and Top 5 Companies by Veterinary Clostridium Vaccines Revenue in 2019
    • 3.2.5 Global Veterinary Clostridium Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Veterinary Clostridium Vaccines Price by Manufacturers
  • 3.4 Veterinary Clostridium Vaccines Manufacturing Base Distribution, Product Types
    • 3.4.1 Veterinary Clostridium Vaccines Manufacturers Manufacturing Base Distribution, Headquarters
    • 3.4.2 Manufacturers Veterinary Clostridium Vaccines Product Type
    • 3.4.3 Date of International Manufacturers Enter into Veterinary Clostridium Vaccines Market
  • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2015-2026)

  • 4.1 Global Veterinary Clostridium Vaccines Market Size by Type (2015-2020)
    • 4.1.1 Global Veterinary Clostridium Vaccines Sales by Type (2015-2020)
    • 4.1.2 Global Veterinary Clostridium Vaccines Revenue by Type (2015-2020)
    • 4.1.3 Veterinary Clostridium Vaccines Average Selling Price (ASP) by Type (2015-2026)
  • 4.2 Global Veterinary Clostridium Vaccines Market Size Forecast by Type (2021-2026)
    • 4.2.1 Global Veterinary Clostridium Vaccines Sales Forecast by Type (2021-2026)
    • 4.2.2 Global Veterinary Clostridium Vaccines Revenue Forecast by Type (2021-2026)
    • 4.2.3 Veterinary Clostridium Vaccines Average Selling Price (ASP) Forecast by Type (2021-2026)
  • 4.3 Global Veterinary Clostridium Vaccines Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Breakdown Data by Application (2015-2026)

  • 5.1 Global Veterinary Clostridium Vaccines Market Size by Application (2015-2020)
    • 5.1.1 Global Veterinary Clostridium Vaccines Sales by Application (2015-2020)
    • 5.1.2 Global Veterinary Clostridium Vaccines Revenue by Application (2015-2020)
    • 5.1.3 Veterinary Clostridium Vaccines Price by Application (2015-2020)
  • 5.2 Veterinary Clostridium Vaccines Market Size Forecast by Application (2021-2026)
    • 5.2.1 Global Veterinary Clostridium Vaccines Sales Forecast by Application (2021-2026)
    • 5.2.2 Global Veterinary Clostridium Vaccines Revenue Forecast by Application (2021-2026)
    • 5.2.3 Global Veterinary Clostridium Vaccines Price Forecast by Application (2021-2026)

6 North America

  • 6.1 North America Veterinary Clostridium Vaccines by Country
    • 6.1.1 North America Veterinary Clostridium Vaccines Sales by Country
    • 6.1.2 North America Veterinary Clostridium Vaccines Revenue by Country
    • 6.1.3 U.S.
    • 6.1.4 Canada
  • 6.2 North America Veterinary Clostridium Vaccines Market Facts & Figures by Type
  • 6.3 North America Veterinary Clostridium Vaccines Market Facts & Figures by Application

7 Europe

  • 7.1 Europe Veterinary Clostridium Vaccines by Country
    • 7.1.1 Europe Veterinary Clostridium Vaccines Sales by Country
    • 7.1.2 Europe Veterinary Clostridium Vaccines Revenue by Country
    • 7.1.3 Germany
    • 7.1.4 France
    • 7.1.5 U.K.
    • 7.1.6 Italy
    • 7.1.7 Russia
  • 7.2 Europe Veterinary Clostridium Vaccines Market Facts & Figures by Type
  • 7.3 Europe Veterinary Clostridium Vaccines Market Facts & Figures by Application

8 Asia Pacific

  • 8.1 Asia Pacific Veterinary Clostridium Vaccines by Region
    • 8.1.1 Asia Pacific Veterinary Clostridium Vaccines Sales by Region
    • 8.1.2 Asia Pacific Veterinary Clostridium Vaccines Revenue by Region
    • 8.1.3 China
    • 8.1.4 Japan
    • 8.1.5 South Korea
    • 8.1.6 India
    • 8.1.7 Australia
    • 8.1.8 Taiwan
    • 8.1.9 Indonesia
    • 8.1.10 Thailand
    • 8.1.11 Malaysia
    • 8.1.12 Philippines
    • 8.1.13 Vietnam
  • 8.2 Asia Pacific Veterinary Clostridium Vaccines Market Facts & Figures by Type
  • 8.3 Asia Pacific Veterinary Clostridium Vaccines Market Facts & Figures by Application

9 Latin America

  • 9.1 Latin America Veterinary Clostridium Vaccines by Country
    • 9.1.1 Latin America Veterinary Clostridium Vaccines Sales by Country
    • 9.1.2 Latin America Veterinary Clostridium Vaccines Revenue by Country
    • 9.1.3 Mexico
    • 9.1.4 Brazil
    • 9.1.5 Argentina
  • 9.2 Central & South America Veterinary Clostridium Vaccines Market Facts & Figures by Type
  • 9.3 Central & South America Veterinary Clostridium Vaccines Market Facts & Figures by Application

10 Middle East and Africa

  • 10.1 Middle East and Africa Veterinary Clostridium Vaccines by Country
    • 10.1.1 Middle East and Africa Veterinary Clostridium Vaccines Sales by Country
    • 10.1.2 Middle East and Africa Veterinary Clostridium Vaccines Revenue by Country
    • 10.1.3 Turkey
    • 10.1.4 Saudi Arabia
    • 10.1.5 U.A.E
  • 10.2 Middle East and Africa Veterinary Clostridium Vaccines Market Facts & Figures by Type
  • 10.3 Middle East and Africa Veterinary Clostridium Vaccines Market Facts & Figures by Application

11 Company Profiles

  • 11.1 Elanco
    • 11.1.1 Elanco Corporation Information
    • 11.1.2 Elanco Description, Business Overview and Total Revenue
    • 11.1.3 Elanco Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 Elanco Veterinary Clostridium Vaccines Products Offered
    • 11.1.5 Elanco Recent Development
  • 11.2 Merck
    • 11.2.1 Merck Corporation Information
    • 11.2.2 Merck Description, Business Overview and Total Revenue
    • 11.2.3 Merck Sales, Revenue and Gross Margin (2015-2020)
    • 11.2.4 Merck Veterinary Clostridium Vaccines Products Offered
    • 11.2.5 Merck Recent Development
  • 11.3 Merial
    • 11.3.1 Merial Corporation Information
    • 11.3.2 Merial Description, Business Overview and Total Revenue
    • 11.3.3 Merial Sales, Revenue and Gross Margin (2015-2020)
    • 11.3.4 Merial Veterinary Clostridium Vaccines Products Offered
    • 11.3.5 Merial Recent Development
  • 11.4 Zoetis
    • 11.4.1 Zoetis Corporation Information
    • 11.4.2 Zoetis Description, Business Overview and Total Revenue
    • 11.4.3 Zoetis Sales, Revenue and Gross Margin (2015-2020)
    • 11.4.4 Zoetis Veterinary Clostridium Vaccines Products Offered
    • 11.4.5 Zoetis Recent Development
  • 11.5 Advaxis
    • 11.5.1 Advaxis Corporation Information
    • 11.5.2 Advaxis Description, Business Overview and Total Revenue
    • 11.5.3 Advaxis Sales, Revenue and Gross Margin (2015-2020)
    • 11.5.4 Advaxis Veterinary Clostridium Vaccines Products Offered
    • 11.5.5 Advaxis Recent Development
  • 11.6 MPLIPHI
    • 11.6.1 MPLIPHI Corporation Information
    • 11.6.2 MPLIPHI Description, Business Overview and Total Revenue
    • 11.6.3 MPLIPHI Sales, Revenue and Gross Margin (2015-2020)
    • 11.6.4 MPLIPHI Veterinary Clostridium Vaccines Products Offered
    • 11.6.5 MPLIPHI Recent Development
  • 11.7 Aratana Therapeutics
    • 11.7.1 Aratana Therapeutics Corporation Information
    • 11.7.2 Aratana Therapeutics Description, Business Overview and Total Revenue
    • 11.7.3 Aratana Therapeutics Sales, Revenue and Gross Margin (2015-2020)
    • 11.7.4 Aratana Therapeutics Veterinary Clostridium Vaccines Products Offered
    • 11.7.5 Aratana Therapeutics Recent Development
  • 11.8 ARKO Labs
    • 11.8.1 ARKO Labs Corporation Information
    • 11.8.2 ARKO Labs Description, Business Overview and Total Revenue
    • 11.8.3 ARKO Labs Sales, Revenue and Gross Margin (2015-2020)
    • 11.8.4 ARKO Labs Veterinary Clostridium Vaccines Products Offered
    • 11.8.5 ARKO Labs Recent Development
  • 11.9 Bayer
    • 11.9.1 Bayer Corporation Information
    • 11.9.2 Bayer Description, Business Overview and Total Revenue
    • 11.9.3 Bayer Sales, Revenue and Gross Margin (2015-2020)
    • 11.9.4 Bayer Veterinary Clostridium Vaccines Products Offered
    • 11.9.5 Bayer Recent Development
  • 11.10 CanFel Therapeutics
    • 11.10.1 CanFel Therapeutics Corporation Information
    • 11.10.2 CanFel Therapeutics Description, Business Overview and Total Revenue
    • 11.10.3 CanFel Therapeutics Sales, Revenue and Gross Margin (2015-2020)
    • 11.10.4 CanFel Therapeutics Veterinary Clostridium Vaccines Products Offered
    • 11.10.5 CanFel Therapeutics Recent Development
  • 11.1 Elanco
    • 11.1.1 Elanco Corporation Information
    • 11.1.2 Elanco Description, Business Overview and Total Revenue
    • 11.1.3 Elanco Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 Elanco Veterinary Clostridium Vaccines Products Offered
    • 11.1.5 Elanco Recent Development
  • 11.12 Colorado Serum Company
    • 11.12.1 Colorado Serum Company Corporation Information
    • 11.12.2 Colorado Serum Company Description, Business Overview and Total Revenue
    • 11.12.3 Colorado Serum Company Sales, Revenue and Gross Margin (2015-2020)
    • 11.12.4 Colorado Serum Company Products Offered
    • 11.12.5 Colorado Serum Company Recent Development
  • 11.13 Epitopix
    • 11.13.1 Epitopix Corporation Information
    • 11.13.2 Epitopix Description, Business Overview and Total Revenue
    • 11.13.3 Epitopix Sales, Revenue and Gross Margin (2015-2020)
    • 11.13.4 Epitopix Products Offered
    • 11.13.5 Epitopix Recent Development
  • 11.14 Genus
    • 11.14.1 Genus Corporation Information
    • 11.14.2 Genus Description, Business Overview and Total Revenue
    • 11.14.3 Genus Sales, Revenue and Gross Margin (2015-2020)
    • 11.14.4 Genus Products Offered
    • 11.14.5 Genus Recent Development
  • 11.15 Hygieia Biological Laboratories
    • 11.15.1 Hygieia Biological Laboratories Corporation Information
    • 11.15.2 Hygieia Biological Laboratories Description, Business Overview and Total Revenue
    • 11.15.3 Hygieia Biological Laboratories Sales, Revenue and Gross Margin (2015-2020)
    • 11.15.4 Hygieia Biological Laboratories Products Offered
    • 11.15.5 Hygieia Biological Laboratories Recent Development
  • 11.16 NEXVET
    • 11.16.1 NEXVET Corporation Information
    • 11.16.2 NEXVET Description, Business Overview and Total Revenue
    • 11.16.3 NEXVET Sales, Revenue and Gross Margin (2015-2020)
    • 11.16.4 NEXVET Products Offered
    • 11.16.5 NEXVET Recent Development
  • 11.17 Nuovo Biologics
    • 11.17.1 Nuovo Biologics Corporation Information
    • 11.17.2 Nuovo Biologics Description, Business Overview and Total Revenue
    • 11.17.3 Nuovo Biologics Sales, Revenue and Gross Margin (2015-2020)
    • 11.17.4 Nuovo Biologics Products Offered
    • 11.17.5 Nuovo Biologics Recent Development
  • 11.18 Valneva SE
    • 11.18.1 Valneva SE Corporation Information
    • 11.18.2 Valneva SE Description, Business Overview and Total Revenue
    • 11.18.3 Valneva SE Sales, Revenue and Gross Margin (2015-2020)
    • 11.18.4 Valneva SE Products Offered
    • 11.18.5 Valneva SE Recent Development
  • 11.19 Vetoquinol
    • 11.19.1 Vetoquinol Corporation Information
    • 11.19.2 Vetoquinol Description, Business Overview and Total Revenue
    • 11.19.3 Vetoquinol Sales, Revenue and Gross Margin (2015-2020)
    • 11.19.4 Vetoquinol Products Offered
    • 11.19.5 Vetoquinol Recent Development
  • 11.20 Virbac
    • 11.20.1 Virbac Corporation Information
    • 11.20.2 Virbac Description, Business Overview and Total Revenue
    • 11.20.3 Virbac Sales, Revenue and Gross Margin (2015-2020)
    • 11.20.4 Virbac Products Offered
    • 11.20.5 Virbac Recent Development

12 Future Forecast by Regions (Countries) (2021-2026)

  • 12.1 Veterinary Clostridium Vaccines Market Estimates and Projections by Region
    • 12.1.1 Global Veterinary Clostridium Vaccines Sales Forecast by Regions 2021-2026
    • 12.1.2 Global Veterinary Clostridium Vaccines Revenue Forecast by Regions 2021-2026
  • 12.2 North America Veterinary Clostridium Vaccines Market Size Forecast (2021-2026)
    • 12.2.1 North America: Veterinary Clostridium Vaccines Sales Forecast (2021-2026)
    • 12.2.2 North America: Veterinary Clostridium Vaccines Revenue Forecast (2021-2026)
    • 12.2.3 North America: Veterinary Clostridium Vaccines Market Size Forecast by Country (2021-2026)
  • 12.3 Europe Veterinary Clostridium Vaccines Market Size Forecast (2021-2026)
    • 12.3.1 Europe: Veterinary Clostridium Vaccines Sales Forecast (2021-2026)
    • 12.3.2 Europe: Veterinary Clostridium Vaccines Revenue Forecast (2021-2026)
    • 12.3.3 Europe: Veterinary Clostridium Vaccines Market Size Forecast by Country (2021-2026)
  • 12.4 Asia Pacific Veterinary Clostridium Vaccines Market Size Forecast (2021-2026)
    • 12.4.1 Asia Pacific: Veterinary Clostridium Vaccines Sales Forecast (2021-2026)
    • 12.4.2 Asia Pacific: Veterinary Clostridium Vaccines Revenue Forecast (2021-2026)
    • 12.4.3 Asia Pacific: Veterinary Clostridium Vaccines Market Size Forecast by Region (2021-2026)
  • 12.5 Latin America Veterinary Clostridium Vaccines Market Size Forecast (2021-2026)
    • 12.5.1 Latin America: Veterinary Clostridium Vaccines Sales Forecast (2021-2026)
    • 12.5.2 Latin America: Veterinary Clostridium Vaccines Revenue Forecast (2021-2026)
    • 12.5.3 Latin America: Veterinary Clostridium Vaccines Market Size Forecast by Country (2021-2026)
  • 12.6 Middle East and Africa Veterinary Clostridium Vaccines Market Size Forecast (2021-2026)
    • 12.6.1 Middle East and Africa: Veterinary Clostridium Vaccines Sales Forecast (2021-2026)
    • 12.6.2 Middle East and Africa: Veterinary Clostridium Vaccines Revenue Forecast (2021-2026)
    • 12.6.3 Middle East and Africa: Veterinary Clostridium Vaccines Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

  • 13.1 Market Opportunities and Drivers
  • 13.2 Market Challenges
  • 13.3 Market Risks/Restraints
  • 13.4 Porter’s Five Forces Analysis
  • 13.5 Primary Interviews with Key Veterinary Clostridium Vaccines Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis

  • 14.1 Value Chain Analysis
  • 14.2 Veterinary Clostridium Vaccines Customers
  • 14.3 Sales Channels Analysis
    • 14.3.1 Sales Channels
    • 14.3.2 Distributors

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Research Methodology
      • 16.1.1 Methodology/Research Approach
      • 16.1.2 Data Source

    Veterinary Clostridium Vaccines market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Veterinary Clostridium Vaccines market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

    Segment by Type, the Veterinary Clostridium Vaccines market is segmented into
    Bacterins
    Toxoids
    Mixtures of Bacterins and Toxoids

    Segment by Application, the Veterinary Clostridium Vaccines market is segmented into
    Swine
    Bovine
    Poultry
    Others

    Regional and Country-level Analysis
    The Veterinary Clostridium Vaccines market is analysed and market size information is provided by regions (countries).
    The key regions covered in the Veterinary Clostridium Vaccines market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
    The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
    Competitive Landscape and Veterinary Clostridium Vaccines Market Share Analysis
    Veterinary Clostridium Vaccines market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Veterinary Clostridium Vaccines business, the date to enter into the Veterinary Clostridium Vaccines market, Veterinary Clostridium Vaccines product introduction, recent developments, etc.
    The major vendors covered:
    Elanco
    Merck
    Merial
    Zoetis
    Advaxis
    MPLIPHI
    Aratana Therapeutics
    ARKO Labs
    Bayer
    CanFel Therapeutics
    Ceva
    Colorado Serum Company
    Epitopix
    Genus
    Hygieia Biological Laboratories
    NEXVET
    Nuovo Biologics
    Valneva SE
    Vetoquinol
    Virbac


    Summary:
    Get latest Market Research Reports on COVID-19 Impact on Global Veterinary Clostridium Vaccines. Industry analysis & Market Report on COVID-19 Impact on Global Veterinary Clostridium Vaccines is a syndicated market report, published as COVID-19 Impact on Global Veterinary Clostridium Vaccines, Market Insights and Forecast to 2026. It is complete Research Study and Industry Analysis of COVID-19 Impact on Global Veterinary Clostridium Vaccines market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,900.00
    $5,850.00
    $7,800.00
    3,093.32
    4,639.99
    6,186.65
    3,453.84
    5,180.76
    6,907.68
    416,882.70
    625,324.05
    833,765.40
    293,247.24
    439,870.86
    586,494.48
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report